Livforsakringsbolaget Skandia’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDOC
AIM
NAMA
SOMRS
KA
Livforsakringsbolaget Skandia's TDOC Position: Q4 2022 in Review
Livforsakringsbolaget Skandia sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 200 shares — an estimated $5K sold.
Livforsakringsbolaget Skandia first reported a position in TDOC in Q2 2020 and held it in 10 quarters. The position peaked at $360K in Q4 2020. 445 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.
- Livforsakringsbolaget Skandia reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
- Livforsakringsbolaget Skandia sold 200 Teladoc Health shares in Q4 2022, an estimated $5K.
- Livforsakringsbolaget Skandia first reported a position in Teladoc Health in Q2 2020 and held it in 10 quarters.
- Livforsakringsbolaget Skandia's Teladoc Health position peaked at $360K in Q4 2020.
- 445 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.
Based on Livforsakringsbolaget Skandia's 13F filing for Q4 2022, filed 13 Feb 2023.